The government has mandated pharma companies to revise the Maximum Retail Price (MRP) of medicines, formulations, and medical devices by Se...

Manufacturers can ensure price compliance at retailer level through revised price list, the authority said in an office memorandum issued W...

The country has reportedly witnessed a shortage in essential medicines to treat diabetes and other life-threatening disease after July 1.

So far, chemists had been selling old stocks of medicines at their pre-GST MRPs and pharma companies were expected to declare the new MRPs ...

"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...

Cardiologists told TOI on Thursday the bioresorbable vascular scaffold (BVS)— the fourth generation and most recent one that dissolves into...

There are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...

EMA’s involvement in the case comes two weeks after the Drugs Controller General of India gave an export certificate to Wanbury to supply d...

A bench of Justice B D Ahmed and Justice Vibhu Bakhru said representatives of the pharma companies hold a meeting with the Director of the ...

"Drug firms followed that practice at risk, as the matter was sub judice," admitted a senior company executive on condition of anonymity.

National Pharma Pricing Authority is studying the judgement and will begin the exercise of calculating the amount overcharged by drug compa...

Other companies that have approached the court include Micro Labs, Lupin, Wockhardt, Intas Pharma, Alembic Pharma and Emcure Pharma.

The government may allow pharma companies one more month from the cut-off date of July 29 to re-label their essential drug products.

The finance ministry last week exempted drug makers from the excise duty on repacking or relabeling, an exception available for 45 days.

This exemption would be available for 45 days after the prices of the essential drugs are notified by National Pharma Pricing Authority.

The domestic pharmaceutical market reported growth of 6.8 % at Rs 6,370 cr for the month of May 2013, IMS Health said in its report here

The government may give drug firms just 45 days to comply with the upcoming pricing regime that promises cheaper essential medicines.